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I.  Introduction 
 
Ohio became the 25th state to pass a medical marijuana law (MML) in June of 2016. The bill, HB-
523, was passed with votes from members of both parties in Ohio’s House and Senate. One might 
expect that this bill, with bipartisan support and the potential to create a multimillion-dollar 
industry in Ohio, would be trotted out by a proud governor. Instead, Governor John Kasich 
refrained from a signing ceremony and quietly signed HB-523 along with dozens of other 
bills(Borchardt, 2016c)  This raises the question, why did Ohio pass an MML in 2016? And 
relatedly, how does Ohio’s MML compare to other states? 
 
The MML passed by Ohio’s General Assembly is a prime example of how the threat of an initiative 
campaign can force legislative action from disinterested or recalcitrant lawmakers (Gerber, 1996). 
In the case of Ohio, direct democracy and shifting policy images forced action from reluctant 
legislators that had historically avoided the issue. And now, these same legislators are in charge of 
implementing the law.  
 
I set out to describe how the adoption of Ohio’s Medical Marijuana Control Program fits into 
broader patterns of policy diffusion and investigate how the law compares to other MMLs in the 
country. First, I review previous states’ experiences with the adoption of MMLs and review the 
literature on policy diffusion. This theoretical context provides a basis for understanding how the 
Ohio MML came to be. Next, I use a recent dataset of MMLs to compare and contrast Ohio’s law 
to others. Finally, using the latest research on medical cannabis and variation in MMLs across the 
country, I describe what to expect as HB-523 is implemented in the state. 
 
This article contributes to the growing body of qualitative diffusion research (Starke, 2013) and 
integrates broader diffusion theories with the specific case of Ohio’s MML. I test hypotheses and 
draw conclusions from the literature using statements by legislators during General Assembly 
proceedings, and interviews with five individuals with expert knowledge of medical marijuana 
policy and Ohio’s law.1  
 
II. Mechanisms of Adoption: Direct Democracy and Shifting Policy Images 
 
A. A Short History of Medical Marijuana Policy in the United States 
 
As of July 2018, thirty states and the District of Columbia have adopted MMLs (National Council 
of State Legislators [NCSL], 2018). The state of California adopted the first medical marijuana 
law in 1996 through voter initiative.  
 
There is some confusion related to what qualifies as an MML. Several organizations including 
nonpartisan groups like the National Conference of State Legislatures [NCSL] and ProCon.org, 
and interest groups such as Americans for Safe Access [ASA] and Marijuana Policy Project [MPP] 
define MMLs as those that “allow for comprehensive public marijuana and cannabis programs.”2 
Laws are identified as “comprehensive” if they meet the following criteria:  
 
1) protection from criminal penalties for using marijuana for a medical purpose; 2) access to 
marijuana through home cultivation, dispensaries, or some other system that is likely to be 
implemented; 3) it allows a variety of strains, including those more than “low THC” or cannabinoid 
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oils; and 4) it allows either smoking or vaporization of some kind of marijuana products, plant 
material or extract.3 (NCSL, 2018) 
 
Therefore, a number of states that have passed limited access marijuana programs (e.g., Alabama, 
Georgia, Kentucky, and 13 other states) are not considered MML states. Figure 1 displays the 
states that have passed MMLs – with colors denoting the years when the state adopted. The map 
shows that the earliest adoptions primarily occurred on the West Coast and Mountain West. Over 
time, the majority of states in the Northeast adopted MMLs. The most recent adopters (depicted in 
light brown) are more regionally scattered than previous adopters. 
 
B. Policy Diffusion 
 
Scholars have studied the diffusion patterns of public policies in the states (F. S. Berry & Berry, 
1990; Gray, 1973; Karch, 2007; Walker, 1969). Diffusion research has focused on four broad 
mechanisms to explain the spread of policies: learning, imitation, competition, and coercion 
(Volden, 2017). Policy learning occurs when states observe the actions of other states, and if 
successful, adopt the policies as their own. Learning occurs in marijuana policy in two ways. 
First, states have learned that the federal government has largely stayed out of the industry. 
Second, states learn from best practices of previous adopters. Imitation occurs when a state 
adopts another law without considering its effectiveness. This is an unlikely mechanism in the 
diffusion of MMLs, as the creation of a program is costly and risks inciting federal action.  
 
Competition describes the process whereby states compete with proximate states for resources, tax 
revenue, and potential jobs (W. D. Berry & Baybeck, 2005; Boehmke & Witmer, 2004). While 
much has been written about the revenue windfalls from tax dollars collected in recreational states, 
there is less evidence of such profits in MML states. However, legislators and voters in recent 
adopting states have been more receptive of market-related appeals and the fact that entrepreneurs 
can create jobs and a small tax base. But, as one local reporter observes, “I think they’ve [Ohio’s 
state legislators] been mindful of the optics of setting up a ‘medical’ system and then taxing the 
heck out of it to gin up money for the state coffers” (IV 2, personal communication, February 28, 
2018). Finally, coercion describes the diffusion process that occurs when states face top-down 
pressures from the federal government through regulations and intergovernmental grants. 
Coercion has been a common mechanism to shape education, environmental and health policy in 
the twenty-first century. However, marijuana policy works in the opposite direction, whereby 
federal policy prohibits the use of medical cannabis. In the diffusion literature, each of these 
concepts have been tested by a number of state-level features that scholars have found to be 
important such as slack resources and state capacity, ideology, fiscal health, neighbor adoption, 
and so on. This has led to a rich and empirically-based body of research on the diffusion of a 
number of laws, including MMLs.   
 
Recent research by Hannah and Mallinson (2018) has demonstrated that the diffusion of MMLs 
spread in more liberal and less religious states, was aided by the direct initiative, and followed a 
pattern of ideological, rather than regional, diffusion. Surprisingly, they found little evidence that 
states were thwarted by actions from the federal government (Hannah & Mallinson, 2018). But as 
Karch (2007) notes, such broad studies have limitations.  
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As such, diffusion is not merely an increase of usage or incidence of a policy or form, but rather 
the result of a dynamic decisionmaking process. Therefore, we must look beneath the aggregate-
level data so often used in such research to understand the individual-level decisionmaking that 
drives state policy diffusion (Karch 2007, p.56). 
 
For this reason, it is important to provide a richer description of the adoption process in Ohio in 
order to illuminate how these broader diffusion processes transpired in one state. I do so by 
synthesizing local reporting on the topic, recording deliberations in the Ohio General Assembly, 
and interviewing individuals who were involved in the process (see appendix) including a 
consultant for the Issue 3 campaign and current industry lobbyist (IV 3), 2 legal counsels for a 
major pro-marijuana liberalization interest group (IV1 and IV4), a reporter for a regional paper in 
Ohio (IV 2), and the director of a pro-medical marijuana interest group (IV 5).  
 
In the next two sections, I discuss how the political landscape changed in Ohio – providing a 
window for policy entrepreneurs to engage and legislators to feel pressure to act. Using interviews 
and statements from legislators, I show that direct democracy compelled legislators and the 
governor to act. This action, in turn, was aided by the reframing of the issue. I show how this 
reframing occurred by analyzing newspaper content. 
 
C. Direct Democracy and Policy Diffusion in Ohio 
 
Direct democracy helped push Ohio’s legislature to adopt an MML in two ways. First, the proposal 
of Issue 3 in 2015 opened up a “policy window” (Kingdon, 1995). As Kingdon (1995) argues, 
policy windows can open as a result of a pressing problem or focusing event; but they can also 
open by changes in the political stream. In particular, advocates used an initiative campaign to put 
marijuana policy on the agenda, elevating a discussion of the topic that had garnered little attention 
historically in the state. Second, a looming initiative proposal by MPP further pressured legislators 
to seriously consider adopting an MML.  
 
Hypothesis 1: Ohio legislators’ adoption of an MML was motivated by the threat of an initiative.  
Scholars have investigated whether direct democracy institutions produce laws that are responsive 
to public demand. About half of the states allow for a direct initiative to be placed on the ballot 
from outside groups.  In states without direct democracy, voters have little opportunity to challenge 
their legislators outside of primary and general elections. But in states with direct democracy, the 
initiative provides voters with an alternative mechanism to both set the policy agenda and enact 
legislation (Phillips, 2008). Thus, direct democracy in states can lead to policies that are closer to 
the median voter on a number of specific policies including abortion policy (Gerber, 1996), tax 
policy (Phillips, 2008), and gay rights (Lax & Phillips, 2009). Moreover, there is evidence that 
states with initiatives produce policy that is broadly more congruent with voter preferences 
(Arceneaux, 2002; Gerber, 1999; Lascher & Hagen, 1996; Lupia & Matsusaka, 2004; Matsusaka, 
2004, 2014). Direct democracy affects policy through direct effects (i.e. passed laws) and indirect 
effects (i.e. the threat of an initiative that forces legislators to produce more congruent policies).  
 
In the case of MMLs, there is evidence that the initiative has had both direct and indirect effects 
on the passage of policy. For example, due to the broad lack of support from elected officials, the 
vast majority of MMLs adopted in the first ten years were done so by ballot initiatives (80%) with 
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legislatures adopting MMLs sparingly and only in fairly liberal states (Hawaii in 2000, Vermont 
in 2004, Rhode Island in 2006). Early on, even sympathetic legislators may have been hesitant to 
use their political capital on a polarizing issue. In fact, the first five initiatives (passed in 1996 and 
1998) passed with less than 60 percent of the vote.4 Analyzing the adoption of MMLs through 
2014, Hannah and Mallinson (2018) found that states with direct democracy were three times as 
likely to adopt an MML, even after controlling for states’ ideology, evangelical population, and 
neighbor adoptions.  
 
In the 2015 general election, ResponsibleOhio poured over twenty million dollars into Issue 3 – a 
measure that would have legalized recreational and medical marijuana (Borchardt, 2015). The 
campaign itself was flawed in a number of ways, most notably, the initiative would have written a 
monopoly of production into Ohio’s constitution. To combat the problematic and poorly written 
initiative, the Ohio legislature placed another amendment on the ballot, Issue 2, that would have 
allowed the Ohio Ballot Board to regulate monopolies and consequently strike down Issue 3 if it 
passed (Whyte, 2015). Issue 3 not only faced resistance from the legislature. The flaws in the 
initiative led even the Drug Policy Alliance and MPP to withhold endorsements (Graham, 2015).  
 
Even though the initiative was voted down by a 2 to 1 margin, the campaign environment and 
polling revealed that the vast majority of Ohioans supported a medical marijuana program (Higgs, 
2015). Consequently, in 2016, Ohioans for Medical Marijuana started gathering signatures for a 
medical marijuana ballot initiative. This organization had the backing of Marijuana Policy Project, 
considered by many to be the “adult in the room” (Borchardt, 2016a). At this point. the legislature 
acted at an “astonishing” pace to write an MML on its own terms (Sandy, 2017).  
 
Two individuals that worked closely on marijuana policy in Ohio confirm the notion that the threat 
of an initiative altered the agenda in Ohio. A legislative counsel with a pro-marijuana interest 
group stated, “The first thing that I recall from Ohio was that there was no chance of medical 
marijuana passing at the legislative level” (IV 1, personal communication, February 28, 2018). 
This sentiment was shared by a consultant who worked on ResponsibleOhio’s Issue 3 campaign. 
“Every year we would propose [an MML] and would never get a committee hearing. Suddenly, 
[Governor] Kasich’s folks and others were in communication within weeks of the failed initiative 
[Issue 3]” (IV 3, personal communication, March 6, 2018). Both sources cite a rapid and 
unexpected shift in the interest of lawmakers. 
 
Therefore, when Ohio House members first began taking up legislation in committee, many in the 
pro-marijuana interest community did not anticipate that the legislators would be able to produce 
a bill. Early on in 2016, law makers worked independently, but soon invited others to the table for 
guidance. As the law evolved, legislators “deferred a lot of heavy lifting on the agencies” (IV 1). 
This feature was most critical in causing MPP to abandon its initiative campaign. MPP had an 
opportunity along with other interest groups and state leaders to aid the agencies in rulemaking 
procedures, and decided to expend resources in those efforts rather than on an expensive initiative 
campaign.  
 
In speeches in the Ohio General Assembly,5 numerous legislators alluded to the threat of an 
initiative as reason to adopt HB-523. In Senate proceedings, Sen. David Burke (R - Marysville) 
argued, 
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Each one of us, regardless of how we vote on this piece legislation, I know reflect the will of our 
districts, and the people that sent us here. That does not occur in a ballot initiative. And worse, a 
ballot initiative can’t change. And the ballot initiative that occurred in Issue 3, and may arise in 
November, totally excludes the General Assembly from any changes. I hope it’s perfect if that’s 
the route people go. (Ohio Senate, 2016, Third Consideration Hearing for H.B. 523, 131st General 
Assembly 2nd sess., May 24) 
 
Meanwhile, in the Ohio House of Representatives, Rep. Kirk Schuring (R – Canton) indicated that 
the legislature was at risk of losing control over the creation of a medical marijuana program.  
 
Those who came in and testified as opponents, he [Chair of House Health Committee, Rep. Steve 
Huffman] always asked the question, “Well, given the situation, would you rather have the General 
Assembly take control of this issue? Or would you rather have outsiders chisel something in to our 
constitution?” And without exception, they said they’d rather have the legislature take control of 
this, take the lead. And that’s what we’re doing. (Ohio House, 2016, Third Consideration Hearing 
for H.B. 523, 131st General Assembly 2nd sess., May 10) 
 
Representative Tim Brown (R – Bowling Green) made a similar argument while encouraging his 
colleagues to vote on HB-523.  
 
But if we have missed something, if the science advances, we need to come back and adjust the 
language, or roll something back, or expand in some area. Because we’ve had the courage to do 
this legislatively, rather than what was proposed to our citizens last November, we can fix it. We 
can alter it. And we can change it because it is a law, that we had the courage to step up and vote 
to support. (Ohio House, 2016, Third Consideration Hearing for H.B. 523, 131st General Assembly 
2nd sess., May 10) 
 
There was a surprising amount of self-congratulatory speech in both chambers. Representative 
Teresa Fedor (D – Toledo) was not convinced that her colleagues had acted with such courage or 
sincerity. In stating her opposition to the bill, primarily over its lack of employment protections 
for patients, she goes a step further to call out many of the legislators for their disingenuous interest 
in the policy.  
 
Kudos to all of those folks who’ve come a long way. Because I do remember two years ago, that 
most of us gave Representative Bob Hagan a belly laugh when he had an amendment, you know, 
that we thought made sense. And I know many of the legislators who had prior bills in both House 
and Senate and it was brave of those leaders to even have a hearing on the issue back then. So, 
we’ve come a long way… For that reason, and some others, you know, legislators only want to 
congratulate themselves when they can only go as far as they can. Because the politics won’t let 
them go any further…. So, you can congratulate yourselves all that you want… But this is a cruel 
joke when citizens find out that they have to leave Ohio to get a job. (Ohio House, 2016, Third 
Consideration Hearing for H.B. 523, 131st General Assembly 2nd sess., May 10) 
 
These comments suggest that proponents and opponents agreed that direct democracy had altered 
the political environment.  
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D. Shifting Policy Images 
 
The diffusion of medical marijuana to Ohio was also aided by shifting policy images around the 
issue. Baumgartner and Jones (2009) define policy images as “how a policy is understood and 
discussed…policy images are always a mixture of empirical information and emotive appeals” (p. 
25-6). The policy images around medical marijuana policy changed over time and in ways that 
made the policy more palatable to be taken up by socially conservative states.  
 
For example, when California was considering legalizing medical marijuana in 1996, California 
Governor Pete Wilson and Senator Dianne Feinstein, along with presidential candidates from both 
parties denounced the initiative. General Barry R. McCaffrey, President Clinton’s drug policy 
advisor, argued that California’s 1996 medical marijuana initiative was a “stalking horse for 
legalization.” He further dismissed the law by arguing, “[W]e should ask ourselves if we really 
want Cheech and Chong logic to guide our thinking about medicine” (Goldberg, 1996). This was 
a typical characterization of medical cannabis in the early years of adoption.  
 
Proponents of medical cannabis fought back by constructing positive and sympathetic images of 
beneficiaries of the policy. Public officials are more likely to be pressured to act on a policy when 
the recipients of that policy are positively constructed (Schneider & Ingram, 1993). The move to 
pass an MML in California was led by gay rights activists such as Dennis Peron and Robert C. 
Randall, mobilized by the AIDS epidemic and the palliative effects of marijuana. That is not to 
say that other conditions like cancer were ignored – but gay rights activists led the way (Werner, 
2001). Schneider and Ingram (1993) write, “[P]olicy sends messages about what government is 
supposed to do, which citizens are deserving (and which not), and what kinds of attitudes and 
participatory patterns are appropriate in a democratic society” (p.334). In a federal structure, the 
definition of deserving and undeserving citizens varies by state; therefore, it’s unsurprising that 
the first MML adoptions came in socially liberal states.  
 
Shifting frames aided in expanding medical marijuana laws to more socially conservative states. 
In particular, research related to the effects of medical cannabis on PTSD (Bonn-Miller, Babson, 
& Vandrey, 2014), epilepsy (Devinsky et al., 2014; Maa & Figi, 2014), and opiate abuse 
(Bachhuber, Saloner, Cunningham, & Barry, 2014; Shi, 2017) allowed for legislators and policy 
entrepreneurs to redefine the policy with these frames in mind. Not only have medical marijuana 
advocacy organizations changed their framing of the issue, they have also partnered with other 
organizations that work closely with patients of these conditions (IV5, personal communication, 
March 22, 2018). 
 
In order to determine whether or not the policy images around medical cannabis have changed in 
the public domain, I search newspapers for the frequency of mentions of medical marijuana with 
these specific health conditions. Molotch and Lester (1975) argue that news “is a function, not of 
the nature of the world ‘out there,’, but of the work of those who must somehow bring into being 
some things which are more important than others” (p. 236). The way in which journalists cover 
MMLs can show how the broader understanding of the policy is changing over time. I include 
cancer in the search with the expectation that mentions of cancer is constant – both in its 
association with medical cannabis and in its frequency of diagnoses. 
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The change in frames around the issue sets up my next two hypotheses. While there are a number 
of ways to approach how a topic is framed – I focus on the shifting emphasis of qualifying 
conditions. That is, appeals made to the public, and covered by the media, will shift over time. In 
particular, these shifts will be made strategically to highlight the most sympathetic of conditions 
and potential patients and to highlight issues most salient to national and state and local interests.  
 
Hypothesis 2: Policy images related to medical marijuana shift over time, from emphasizing AIDS 
and HIV to discussing conditions that recent research has connected to medical marijuana.    
 
Hypothesis 3: Policy images related to medical marijuana in local coverage are more likely to 
mention the opioid crisis than other conditions.  
 
I retrieved articles for analysis using a Lexis Nexis keyword search for “medical marijuana” and 
specific health conditions including: Cancer, HIV/AIDS, epilepsy, PTSD, traumatic brain injuries, 
and opioids (see Table 1). The search is set up to return articles that included medical marijuana 
in the headline or lead along with the specified medical condition.   
 
Figure 2 displays the number of mentions of each of these conditions over time in the New York 
Times (NYT). For comparison, I ran identical searches in the Washington Post to show the results 
are similar to the NYT (see Figure A1 in the appendix).  
 
It is important to note that the articles are not mutually exclusive. Articles that include multiple 
diagnoses are frequently double-counted in the analysis. But this feature should give strength to 
the measure. That is, the news content results do not just indicate an ever-growing list of qualifying 
conditions, rather many of these articles do not include conditions historically connected to 
medical cannabis and instead focus on new conditions. Journalists are making a conscious choice 
to elevate some conditions over others.  
 
Figure 2 shows how the framing of medical marijuana policy has evolved. In particular, there is 
an uptick in attention to post-traumatic stress disorder, associated with veterans suffering from the 
effects of PTSD from the wars in Iraq and Afghanistan (Jonsson, 2018). And there is increased 
frequency of articles that mention epilepsy, a change borne largely out of the efforts of the 
“mommy lobby” and new research related to the effect cannabinoid oils can have on mitigating 
seizures (Cha, 2014; Maa & Figi, 2014; Pickert, 2014). Finally, the opioid crisis, and the 
exponential increase in heroin use starting around 2010, has garnered more attention in news 
coverage of medical marijuana (Wilkerson, Kim, Windsor, & Mareiniss, 2016). As expected, 
mentions of cancer are prominent throughout the analysis. Even though there are a number of 
journalists and medical professionals that argue these connections are overhyped (Hall et al., 2018; 
Lopez, 2018), currently more coverage is given to the potential of medical cannabis to allay these 
public health concerns.  
 
To test my next hypothesis, I retrieve articles from The Dayton Daily News (DDN).6 By the time 
Ohio takes up the policy, the opioid epidemic is a prominent issue in the state’s politics. Journalists 
in Ohio would be motivated to only cover medical marijuana when it becomes a serious 
proposition, and also do so in a way that is most relevant to their readership. Figure 3 shows the 
trends in DDN coverage of medical marijuana from 1995 to 2017.  
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The results from the DDN confirm the hypothesis that the opioid epidemic is prominent in medical 
marijuana news coverage. However, it is surprising that cancer is mentioned at a much higher rate 
- 15 times in both 2016 and 2017. Moreover, AIDS and epilepsy are both mentioned more than 
PTSD – a surprising trend given Dayton’s military population. The search also shows that medical 
marijuana was rarely mentioned prior to the policy becoming a statewide issue – consistent with 
differences in national and regional coverage (Birkland & Waterman, 2008).  
 
While I could not replicate the same analysis in other publications, there is evidence that other 
regional Ohio papers emphasized these same themes. As the law was arriving on Governor 
Kasich’s desk, the Cincinnati Enquirer published a long profile on a mother, a veteran, and a 
woman with chronic pain (Balmert, 2016a). Meanwhile, the Toledo Blade ran a similar profile in 
an article titled “Area patients praise medical marijuana benefits” that focused on a mother of a 
child with Dravet syndrome, a nurse dealing with chronic pain from an accident, and a retired 
police officer who questioned the efficacy of marijuana enforcement (Henry, 2016). Finally, the 
Plain Dealer ran an article titled “Could medical marijuana solve Ohio’s opioid problem?” 
(Borchardt, 2016b).7  
 
The newspaper content analysis shows that frames related to medical cannabis have changed over 
time. What cannot be teased out is the causal mechanism. The trend is likely explained by a 
combination of the changing way journalists view the issue, economic pressures to discuss policies 
in terms most relevant to readers, and shifting strategies from advocates and lawmakers to frame 
the issue in the most salient and compassionate ways. 
 
Consider how Senator Kenny Yuko (D-Youngstown) discussed the issue on the Senate floor:  
 
Well a person my age, when you heard of marijuana back in those days, back in 2003, When I 
heard two words associated with marijuana, it wasn’t ‘medical’ and ‘marijuana’.  It was more like 
‘Cheech’ and ‘Chong’, ‘Snoop’ and ‘Dog’, and ‘Willie’ and ‘Nelson’… The reality of it is, once I 
did a little research, I found out how wrong I was…This bill is not perfect folks, but it’s what Ohio 
patient [sic] needs. It’s not acceptable to make them wait any longer. If we can give just one veteran 
comfort, if we can ease one patient’s horrible pain, if we can maybe improve or even save a child’s 
life, this bill will be worth it. (Ohio Senate, 2016, Third Consideration Hearing for H.B. 523, 131st 
General Assembly 2nd sess., May 24) 
 
The analysis so far has shown how direct democracy and shifting frames are important factors in 
the diffusion of medical cannabis to Ohio. I have demonstrated the face validity to this narrative 
through evidence from the literature, interviews, and an analysis of newspaper coverage. But if the 
adoption of this law required institutional and political pressures, does the actual content of the 
law differ from prior adopters? Such analysis has been a limitation with many studies of diffusion. 
Graham, Shipan, and Volden (2013) observe: 
 
Even when one focuses solely on the spread of public policies, however, diffusion studies tend to 
ignore a wide range of relevant questions, including how ideas find their way onto the agenda, how 
agenda items become laws, whether laws are just ideas until an implementer turns them into actual 
policies, and so on. This emphasis on stages of the policy process has long been central to public 
policy, yet the diffusion literature sets aside the early and later stages of the policy making process 
and focuses almost exclusively on the adoption stage. (p. 689) 
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This is not the first appeal for diffusion research to address individual behaviors, implementation, 
and the content of laws. Andrew Karch (2007b) notes this criticism of diffusion research is brought 
up frequently, but rarely addressed. Karch (2007b) calls for an emphasis on “What is being 
diffused”, as he notes, “Ignoring the question of policy content, as most state policy diffusion 
research has done, fails to address an important aspect of variation across space and time that has 
both theoretical and practical implications” (p. 69). 
  
In the next section, I compare and contrast Ohio’s MML with other state MMLs. I find that Ohio’s 
law is consistent with some trends of recent adopting states, particularly with regards to expanding 
the qualifying conditions but limiting personal cultivation and smoking. With regard to these 
features, the content of Ohio’s law is best explained by temporal trends rather than ideological 
ones. The law lists more qualifying conditions than the majority of states, but has been criticized 
for its lack of employment protections.  
 
III. What is in Ohio’s Law? 
 
A. Variation in Language in MML Laws 
 
As MMLs have been adopted by more states, scholars have started to investigate the heterogeneity 
of these laws (Chapman, Spetz, Lin, Chan, & Schmidt, 2016; Klieger et al., 2017; Pacula, Powell, 
Heaton, & Sevigny, 2014; Pacula & Sevigny, 2014). Legislatures creating MMLs have to account 
for a number of factors governing patients, caretakers, doctors, law enforcement, prosecutors, 
producers, and entrepreneurs.  
 
Understanding these differences in the content of MMLs is important for policy analysis. Thus far, 
the majority of research treats the features of an MML as an independent variable predicting a 
public health outcome as the dependent variable. For example, studies have shown that MMLs are 
associated with a decrease in painkiller overdoses (Bachhuber et al., 2014), fewer hospitalizations 
due to opiates (Shi, 2017), decreased prescriptions and spending in Medicare Part D (Bradford & 
Bradford, 2016), and fewer fatal car accidents due to opiates among 21-40 year-olds (Kim et al., 
2016). Scholars have just started to explore the nuance of the laws and some have challenged the 
conclusions of the aforementioned studies (Hall et al., 2018).  
 
To better understand how Ohio’s MML compares to others, I use data from the Prescription Drug 
Abuse Policy System (http://www.pdaps.org) on MMLs created by Klieger and colleagues (2017). 
Two legal researchers coded each of the twenty-eight MMLs as they existed in 2017 and created 
three empirical data sets.8 The three datasets focus on state laws governing marijuana patients 
(coded for all states), product safety (coded for 22 states that include such provisions)9, and 
dispensaries (coded for 25 states); each dataset contains binary indicators of whether a state’s law 
does or does not contain a provision.  
 
B. Ohio’s Medical Marijuana Control Program in Context 
 
Laws in every state have listed qualifying conditions in their MMLs. Figure 4 displays the number 
of qualifying conditions listed in each state law plotted over the year in which the state passed the 
law and shows a trend of states including more conditions over time. This is evident in Ohio’s law, 
which lists more qualifying conditions (16) than all but two states. Ohio’s MML is one of a 
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minority of states that includes traumatic brain injuries, inflammatory bowel disease, Tourette’s 
syndrome, and Alzheimer’s disease. Ohio’s law, along with 21 other states (79%), also includes a 
provision for adding to the list of qualified conditions.  
 
Many of the early states to adopt an MML did not include patient registries. After federal guidance 
in 2009 (Ogden, 2009), all states except for Florida and Minnesota require patient registries. The 
Ohio Medical Marijuana Control Program finalized guidelines and rules in September of 2017, 
but the registry has yet to be opened to patients.10 
 
When Ohio legislators took charge in writing their own law, MPP was in the midst of a signature 
gathering campaign for their own initiative to appear on the 2016 ballot. Though eventually 
dropped, MPP’s campaign for an initiative that would have differed in two critical ways from the 
law that was passed in the legislature. It would have allowed for home cultivation and for smoking 
marijuana. Republican State Sen. David Burke, a co-sponsor of the bill, told reporters, “Smoking 
dope and growing dope, that’s not an Ohio thing” (Balmert, 2016b). “Smoking is a boogie man 
for lawmakers” (IV1). Law makers are careful to write laws that do not alert fears of de facto 
recreational marijuana, so smoking has become increasingly scrutinized as inconsistent with other 
medications. Advocacy groups have conceded on smoking, as long as some form of vaporizing is 
an option as some conditions require a rapid onset delivery in order to provide pain relief (IV1). 
The restriction of smoking is common in recent state laws (NY, MN, FL, PA).  
 
The program also sets limitations on home cultivation. On this point, Ohio’s MML is part of a 
growing trend. Of the eighteen states that have adopted or modified MMLs since 2010, all but five 
have restricted home cultivation (72%). The five states that do allow home cultivation have all 
passed the law via initiative. Twelve of the thirteen states that do not allow home cultivation passed 
MMLs in the legislature (Klieger et al., 2017).11 But this trend has some downsides according to a 
legal counsel with a pro-marijuana interest group. In particular, some states have been reluctant to 
provide dispensary licenses, making the state-controlled market small and often vertically 
integrated, driving up prices (IV4, personal communication, March 9, 2018). Moreover, potential 
patients are dependent on the state to get the program up and running. 
 
Ohio’s law fits the depiction of a “medicalized” program (A. R. Williams, Olfson, Kim, Martins, 
& Kleber, 2016). Williams and colleagues (2016) examined the first twenty-four medical 
marijuana laws “according to seven components of traditional medical care and pharmaceutical 
regulation” (p. 480). They determined that fourteen of the twenty-four programs were 
“nonmedical” and contained few regulations. Next, they compared patient enrollment in 
medicalized and nonmedical programs. They determined that over 99 percent of nationwide 
enrollment in medical marijuana programs occurred in nonmedical states. In general, the 
nonmedical programs were older (10 years on average) and in the West (all 10 programs in the 
region are labeled nonmedical).  
 
Table 2 displays the features of MMLs organized by region. Most of the earliest adopting states 
are located in the West, adopted via direct democracy, and contain programs that are nonmedical. 
As the policy has evolved and spread to other regions, it has become increasingly medicalized. 
Thus, one can expect that the medicalized nature of these laws will also affect implementation.  
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One of the most significant criticisms of the law has been related to provisions that protect 
employers. While Ohio received a passing mark from Americans for Safe Access (2017), the 
medical cannabis advocacy organization also notes: 
 
If Ohio can move through the implementation in a timely manner and adopt strong product safety 
protocols it could be one of the stronger programs in the country. However, the medical cannabis 
law includes the worst employment language in the country for patients, making employment 
discrimination against patients lawful and explicitly denies patients a cause of action in court to 
challenge employment discrimination cases. (p. 137) 
 
In House proceedings, Rep. Teresa Fedor (D – Toledo) spoke in opposition to the bill primarily 
for the employment language. Describing the catch-22 that patients would face, Rep. Fedor argued, 
“[S]o go ahead and use medical marijuana, but you’ll be discriminated against when you are well 
enough to get a job” (Ohio House, 2016, Third Consideration Hearing for H.B. 523, 131st General 
Assembly 2nd sess., May 10). Employers are given broad discretion in how they treat medical 
marijuana patients. They can use drug tests to screen job candidates, prohibit medical use, and 
discipline workers for cannabis use. Moreover, workers fired for marijuana-use will not have 
access to unemployment benefits or workers’ compensation. The discretion does cut both ways, 
as employers are also allowed to set different standards based on the mental and physical demands 
of the job  (M. Williams, 2018). 
 
IV. Implementing Medical Marijuana in Ohio 
 
A. The Regulatory Environment 
 
The process of implementing Ohio’s medical marijuana law is still developing. Not unlike other 
programs, the program has faced a number of delays and failed to open on its targeted 
implementation date of September 8, 2018. The best way to understand the implementation is to 
examine six key areas: Cultivation, processing, testing, dispensaries, physicians and patients. 
Physicians and patients are listed last. Since the law does not permit home growth and 
cultivation, physicians and patients are dependent on the development of the industry (Borchardt, 
2018; Simmons, 2018).  
While the state may be prepared to serve patients, the supply of cannabis is bogged down in 
regulation. In fact, Grant Miller, a spokesman for the pharmacy board, recently commented on 
the delay in rolling out the patient registry, “The registry has been tested, and we’re confident in 
its functionality and usage. It basically just has to be turned on. Whenever we have a date, we’ll 
be ready” (Tucker, 2018b). The number of potential patients is unknown, although 185 Ohio 
doctors have obtained a “certificate to recommend” (CTR) on their medical license (Simmons, 
2018). 
Figure 5 displays details and the latest status (as of July 2018) related to the cultivation, 
processing, testing, and dispensaries process in Ohio. The figure shows the process medical 
cannabis must go through before patients have access and each step is dependent on the previous 
one. With the state only recently approving the first cultivator to start planting; processors, 
testing labs, and dispensaries are left waiting. These delays are largely due to the regulatory 
environment and local politics. As one interviewee put it, “whenever you create a multimillion-
53
Hannah: Medical Marijuana in Ohio
Published by Carroll Collected, 2018
 
dollar policy, there’s going to be issues” (IV 3). They continued, “[I]t’s clear that the state did 
not hire enough graders. [The] Department of Commerce did not have enough staff and 
manpower. They didn’t have malice or intend to drag their feet, but they weren’t enthusiastic 
either” (IV 3). The lack of graders (and background of one) and lack of transparency about the 
process have led to a series of lawsuits and contributed to the delays (Bischoff, 2017; Tucker, 
2018a).   
B. Local Control 
 
While localities cannot prohibit patients or physicians to use or prescribe medical cannabis, they 
can restrict cultivators, processing facilities, and dispensaries from operating in their boundaries. 
Many localities moved to pass bans or moratoriums on the marijuana industry drew heightened 
interest from citizens concerned about expanding marijuana into their backyard. This added 
uncertainty for industries trying to move into Ohio as they had to navigate state regulations while 
also negotiating with local communities over property and zoning rules (Knox, 2017).  
For example, Beavercreek’s city council passed a six-month ban on the industry in January of 
2018. However, a company applied for a dispensary license in Beavercreek prior to the ban and 
was awarded a state license in June. This has led to major debates about whether the township 
will set a ban, likely facing a lawsuit, or work with the one dispensary but limit expansion 
(Wilson, 2018).  
But, other localities have lifted moratoriums, motivated by potential tax revenue and jobs. A 
councilman regretted passing a moratorium in Lima, arguing “We need to keep ourselves in the 
game” (Ellerbrock, 2018). The city of Cleveland lifted a year-long moratorium, with some citing 
the fact that Boston added millions of tax revenue after Massachusetts passed a similar program 
(Higgs, 2015).  
The concerns that have come up in communities have varied. For example, in Marietta, citizens 
voiced concerns over an approved dispensary’s location near a busy intersection and its 
proximity to a stadium that is used by local high schools (Patterson, 2018). Due to federal 
regulations, the marijuana industry runs on a largely cash-based system - citizens in Dayton 
expressed fear that the industry would attract crime (Stewart, 2018). In Marion, council members 
feared added foot traffic downtown and the pressure it would put on a cash-strapped police force 
(Volpenhein, 2017). But, in Gibsonburg (Sandusky County), the police chief supported medical 
marijuana, arguing it could help with the opioid epidemic. He went on to discuss the potential 
economic benefits. “First, it’s a new business in Gibsonburg and in the county, and we can’t 
police without tax money” (Shoup, 2018). 
In summary, the regulatory environment combined with local ordinances have delayed the 
implementation of the program. This is not uncommon. Given the complexity of regulating a 
newly created program and the federal government’s ambiguous position, many state programs 
have taken years to get off the ground (Breitenbach, 2015).  
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V. Concluding Remarks 
This paper sheds light on the adoption process of an MML in Ohio and on the structure of the law. 
Passing an MML in Ohio required a transformation of the political landscape. A looming initiative 
campaign combined with shifting policy images motivated legislators in Ohio to adopt an MML. 
Legislators created a law consistent with recent adopters, but also included provisions that were 
most palatable to their constituents, particularly in terms of prohibitions on cultivation and 
smoking, employer protections and local control. And now, politics will shape the implementation 
of the law.  
Questions remain about how the law will ultimately be implemented. One of the most common 
arguments for passing the law in the legislature, and not by initiative, was that legislators would 
be able to maintain control over a program that they developed. This feature could lead to two 
different outcomes. On the one hand, the legislature has the flexibility and statutory authority to 
monitor implementation and make improvements to the program and law. On the other hand, 
elected leaders in Ohio might know that they did just enough to thwart an initiative campaign, but 
be less devoted to the implementation of the law. Moreover, the environment could completely 
change if a recreational marijuana initiative, scheduled for the 2019 election, makes the ballot and 
gets approved (Garbe & Bischoff, 2018).  
New Jersey provides an instructive case for how politics affect the implementation of an MML. 
The New Jersey legislature passed an MML in 2009 that outgoing Democratic Governor Jon 
Corzine signed in January of 2010, on his last day in office (Heininger, 2010). Republican 
Governor Chris Christie remained skeptical of the program for his entire term, and the program 
was largely viewed as untenable for doctors, patients, or providers (Johnson, 2014). As a 
consequence, the program remained small. For example, New Jersey and Michigan are similarly 
sized states that passed programs around the same time; at the start of 2018, New Jersey had 15,000 
card-holding members in its program compared to 220,000 members in Michigan (Livio, 2018). 
As Democratic Governor Phil Murphy took office in 2018, he tasked the Department of Health 
with making a workable law and prioritized medical access to marijuana (IV4, personal 
communication, March 9, 2018). After four months in office, the patient registry doubled (Nash, 
2018). 
The future of medical marijuana policy in Ohio may be determined by the 2018 statewide elections 
in Ohio. While it is unlikely to be a key campaign issue, the results may have significant 
ramifications for implementation. Asked about the outgoing governor’s role in implementation, 
“Kasich doesn’t care. It’s [the MML] a gnat flying over his head, and he just wants to whack it 
away. He’s not a true believer [in the policy]” (IV 3). Ohio’s Medical Marijuana Control Program 
may not take off if this trend continues, or if the newly elected administration has similar 
sentiments. This process serves as a reminder of classic government truths – institutions matter 
and elections have consequences. Both are prescient in the case of Ohio’s medical marijuana 
program.  
 
 
 
 
55
Hannah: Medical Marijuana in Ohio
Published by Carroll Collected, 2018
 
TABLES 
Table 1: Mentions of Medical Marijuana with specific public health issues (1995-2017) 
Search terms 
HLEAD(medic! w/5 marijuana)a + 
New York 
Times 
Washington 
Post 
Dayton Daily 
News 
Cancer 199 204 40 
HIV or AIDS 160 176 14 
PTSD or TBI or traumatic 18 45 6 
Seizure or epilepsy 73 94 14 
Opioid or opiate or heroin 76 124 25 
a Syntax used in LexisNexis search. 
 
 
Table 2: Features of MMLs by US Region 
 West Northeasta Midwest South 
Number of state 
with MMLs 
10 12 4 4 
Average year of 
adoption 
2001 2010 2014 2016 
Number of 
medicalized 
programs 
0 4b 3 3 
MML passed by 
Initiative 
8 2 1 1 
a Author used U.S. Census regional codes for guidance but included DE, MD, and DC in Northeast 
Region because they have more in common with Eastern Seaboard states than other southern adopters – 
AR, FL, OK, and WV. 
b Williams et al. (2016) did not include NH and MA in their final analysis. 
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FIGURES 
Figure 1: States with Comprehensive Medical Marijuana Laws (1996-2018) 
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Figure 2: Mentions of Medical Marijuana in The New York Times with specific public 
health issues (1996-2017) 
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Figure 3: Mentions of Medical Marijuana in the Dayton Daily News with specific public 
health issues (1996-2017) 
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Figure 4: Number of qualifying conditions listed in MML over time.  
 
Note: Based on dataset constructed by Klieger et al. (2017) 
 
 
Figure 1: Ohio Medical Marijuana Control Program – Status of Implementation (July 
2018) 
 
    NOTE: Data from Borchardt (2018) and Simmons (2018). 
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APPENDIX 
 
Elite Interviews Protocol 
 
In order to better understand the adoption of and design of Ohio’s MML I reached out to several 
organizations. In particular, I looked for organizations that were active in the legislation 
according to press reports (Public Relations in Table A1). Next, I reached out to those 
organizations via email or social media. Surprisingly, some organizations were more responsive 
to social media rather than email requests.  
 
Table A1 shows the three different approaches. The outreach category includes public figures 
and organizations that I reached out to with no internal contacts. The personal contacts category 
includes individuals that I was connected with through another professional contact or already 
had a professional relationship with. Finally, many of the interviewees would make 
recommendations during our interview. In those cases, I was introduced to the contact via email.  
The names in bold correlate to how each is labeled in the text. 
 
Of the 11 individuals or groups that I reached out to, I successfully completed an interview with 
six of them. Unsurprisingly, active legislators appeared most reluctant (or too busy) to agree to 
an interview. While each of the interview subjects approved of using their name and title, I 
decided to use titles and labels as shorthand and to follow conventions in the academic literature 
(Mosley, 2013). 
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Table A2: Interview Protocol 
Interviewee Status Source 
Strategy 1: Outreach   
Legislator 1 (retired) 
 
Agreed to interview (March 1, 2018), 
Responded to follow-up request 
(March 13, 2018). Did not reply to 
emailed questions. 
Facebook and email 
Legislator 2 (active) - 
Proponent 
No response (March 6, 2018) Legislator’s Website 
Legislator 3 (active) - 
Opponent 
No response (March 8, 2018) Twitter 
Pro-Medical Marijuana 
Interest Group 1 – Legal 
Counsel 1 
IV 1 
Agreed to interview (February 27, 
2018), Interview conducted by phone 
on February 28, 2018 
Facebook and 
organization website 
Pro-Medical Marijuana 
Interest Group 2 – Director 
 
IV 5 
 
Agreed to interview (February 24, 
2018), Interview scheduled (March 22, 
2018) 
Organization 
Website 
Anti-Medical Marijuana 
Interest Group 
No response (March 8, 2018) Organization 
Website 
Strategy 2: Personal 
Contacts 
 
  
Journalist 
 
IV 2 
Agreed to interview (February 28, 
2018). Emailed responses to my 
questions (March 1, 2018) 
Email 
Consultant – Responsible 
Ohio and marijuana industry 
 
IV 3 
Agreed to interview (March 5, 2018), 
conducted interview (March 7, 2018).  
Email 
Strategy 3: 
Recommendations 
  
Legislator 2 (active) No response (March 6, 2018) Legislator’s Website 
Pro-Medical Marijuana 
Interest Group 1 – Legal 
Counsel 2 
IV 4 
Agreed to interview (March 1, 2018), 
Conducted interview (March 9, 2018) 
Personal contact 
from legal counsel 1 
Co-Founder and CEO of 
medical marijuana cultivator 
and distributor 
 
 
Agreed to call in for interview (March 
8, 2018), did not call on two 
subsequent attempts (March 15, 2018 
and March 19, 2018). 
Company Website 
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News Attention Analysis 
 
Using LexisNexis Academic, I search for articles that include “medical marijuana” in the 
headline and lead of articles and include references to key conditions that are treated with 
medical marijuana. Table 1 shows the search terms and the number of returns from The New 
York Times, the Dayton Daily News, and The Washington Post. I only report data for The New 
York Times and Dayton Daily News in the main text. While articles were collected from 1975 
onward, the mentions are sparse until the early 1990s. Figures 1 and A1 show trends from 1995 
onward, the same period when modern MMLs were first adopted. 
 
The results from The Washington Post are collected to further validate the NYT measure. The 
trends for both papers are generally the same, although it is worth noting that The Post ran 
several stories related to the NFL and opioids and the New York Times’ spike in attention in 2014 
is related to the state legislature in New York passing the law.  Below is the syntax for each of 
the searches:  
 
HLEAD(medic! w/5 marijuana) AND (opioid or opiate or heroin) 
 
The command HLEAD returns articles that included marijuana and a stem of “medic” such as 
“medicinal”, “medical”, etc. The “w/5” command means it searches for these two terms located 
within five words of each other. For example, an article that discusses “marijuana used as 
medicine” would be returned under this search. The AND operator directs LexisNexis to only 
return articles with medical marijuana in the headline or lead that also include (opioid, opiate, or 
heroin). It is worth noting that the articles are not mutually exclusive. Articles that include 
multiple diagnoses are double-counted in the analysis. This feature should give strength to the 
measure. That is, it’s not just that articles starting mentioning opiates as a condition that could be 
treated by medical marijuana, it’s that many of these articles do not include the list of previous 
conditions such as HIV/AIDS/ PTSD/etc. We can assume this means that they are elevating the 
role of medical marijuana as it pertains to opiates/epilepsy/etc. compared to other conditions.  
 
I considered other nonmedical ways in which the issue might be framed. For example, I searched 
for “‘countercult!’ OR ‘hipp!’ OR ‘recreation!’” as well as “gateway” to determine the extent 
that nonmedical frames were used. These searches produced a few articles with no clear patterns.  
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Figure A1 Mentions of Medical Marijuana in The Washington Post with specific public 
health issues (1996-2017) 
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ENDNOTES 
 
 
 
1 The author consulted with their university’s Institutional Review Board about the interviews. 
The IRB ruled that this research is not considered human subjects research under the Common 
Rule. Therefore, no further action was necessary.  
2 NCSL - http://www.webcitation.org/6qv4nUpXN  
3 From NCSL web page accessed 9 February 2018 - http://www.webcitation.org/6qv4nUpXN   
4 NCSL Ballot Measures Database accessed 10 March 2018 
  http://www.ncsl.org/research/elections-and-campaigns/ballot-measures-database.aspx  
5 Ohio General Assembly proceedings available on The Ohio Channel, accessed on 2 March 
2018. Transcribed by author. House - http://www.ohiochannel.org/video/ohio-house-of-
representatives-5-10-2016; Senate - http://www.ohiochannel.org/video/ohio-senate-5-25-2016-
part-2  
6 LexisNexis Academic does not include other regional papers in Ohio such as the Cleveland 
Plain Dealer or Columbus Dispatch. While combining these papers would be ideal, I chose to 
analyze the Dayton Daily News in the same program as the analysis of the NYT and Washington 
Post. Admittedly, the fact that Dayton is considered one of the most hard hit cities by the 
epidemic, the framing of opiates might be higher than if averaged out with other Ohio regional 
papers. 
7 Surprisingly, I found no evidence that papers in Southeast Ohio were making the same  
connection. In fact, the passage of the policy received little coverage. This may be due to  
the papers working with fewer resources. I also cannot rule that these papers might have  
included articles from other publications like the Associated Press that made these  
connections. 
8 It is important to emphasize the laws were coded as they existed on that date. Several state laws 
have been revised. For example, California passed the first medical marijuana law in 1996 but 
this law was amended in 2003. When discussing temporal trends in the content of laws, I use the 
year in which the law was last updated rather than when it was first passed. West Virginia and 
Oklahoma passed laws after the creation of the dataset and are not included in the dataset - 
http://www.webcitation.org/6xWZCTuBf 
9 Ohio’s law has not been coded for provisions on product safety 
10 Guidelines are available at https://medicalmarijuana.ohio.gov/patients-caregivers  
11 Florida is the only state that both restricts home cultivation and passed the law via initiative.  
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